86

LITERATURVERZEICHNIS

Agren H, Lundquist G : "Low levels of somatostatin in human CSF make depressive episodes" . Psychoneuroendocrinology . 9 : 233-248 , 1984

Alvir, J.M.J.: "Clozapine-induced agranulocytosis. Incidence and risk factors in the United States" . Engl J Med. 329 : 162-167 , 1993

Amar A, Segman R, Shtrussberg S, Sherman L, Safirman C, Lerer B, Brautbar C. "An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201" . Intern J Neuropsychopharmacol. 1 : 41-44 , 1998

Arana GW, Baldessarini RJ : "Clinical use of the dexamethasone suppression test in psychiatry. In: Meltzer HY (ed) Psychopharmacology:" The third Generation of Progress. New York: Raven Press, 609-615 , 1987

Arato M, Banki CM, Bissette G, Nemeroff, CB : "Elevated CSF CRF in suicide victims. " Biol Psychiatry. 25 : 355-359 , 1989

Arbiser JL, Morton CC, Bruns GAP, Majzoub JA : "Human corticotropin-releasing hormone gene is located on the long arm of chromosome 8" . Cytogenet Cell Genet . 47: 113-117 , 1988

Arranz MJ, Munro J, Sham P, Kirov G, Murray RM, Collier DA, Kerwin RW : "Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response" . Schizophr Res . 32: 93-99 , 1998

Arthur H, Dahl ML, Siwers B, Sjoqvist F ": Polymorphic drug metabolism in schizophrenic patients with tardive dyskinesia" . J Clin Psychopharmacol. 15: 211-216 , 1995

Asnis GM, Eisenberg J, Lemus CZ, Halbreich U : "Dexamethasone suppression test in schizophrenia" . Neuropsychobiology . 15: 109-113, 1986

Austin GE, Zhao WG, Zhang W, Austin ED, Finley HW, Murtagh JJ Jr.: "Identification and characterization of the human myeloperoxidase promotor" . Leukemia . 9: 848-857 , 1995

Austin GE, Chan WC, Zhao W, Racine M : "Myeloperoxidase gene expression in normal granulopoiesis and acute leukemias" . Leuk Lymphom 15: 209-226 , 1996

Axelrod J, Reisine D : "Stress-hormones: their interaction and regulation" . Science . 224: 452-459 , 1984

87

Balldin J, Berggren UC, Lindstedt G : "Neuroendocrine evidence for reduced dopamine receptor sensitivity in alcoholism" . Alcohol Clin Exp Res 16: 71-74 . 1991

Balldin J, Berggren U, Lindstedt G, Sundkler A : "Further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism" . Drug Alohol Depend . 32: 159-162 , 1993

Banki CM, Bissette G, Arato M, O’Connor L, Nemeroff MS, Nemeroff CB : "CSF corticotropin-releasing factor-like immunorectivity in depression and schizophrenia" . Am J Psychiatry . 144: 7-11 , 1987

Batchelor JR, Welsh KI, Mansilla TR, Dollery CT, Hughes GRV, Bernstein R : "Hydralazine-induced lupus erythematosus: influence of HLA-DR and sex on susceptibility" . Lancet . 1:1107-1109 , 1980

Bech P, Rafaelsen OJ, Kramp P, Bolwig TG: "The mania rating scale: Scale construction and inter-observer aggreement. " Neuropharmacology. 17:430-431 , 1978

Berton F, Francesconi WG, Madamba SG, Zieglgansberger W, Siggins GR : "Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons. " Alcohol Clin Exp Res . 22: 183-91 , 1998

Bissette G, Spielman F, Stanley M, Banki CM, Fink M, Tröskman-Bendz L, Golden RN, Arato M, Nemeroff CB : "Further studies of corticotropin-releasing factor-like immunoreactivity in CSF of patients with affective disorders" . Soc Neurosci Abstr. 11, 133, 1985

Bissette G, Walleus H, Widerlov E, Karlsson I, Eklundt K, Loosen PT, Nemeroff CB : "Reductions of cerebrospinal fluid concentrations of somatostatin-like immunoreactivity (SRIF-LI) in dementia, major depression and schizophrenia" . In : Abstracts of the 14th. Annual Meeting of the Society of Biological Psychiatry . p177, (Abstr. 135) 1986

Bissette G, Widerlov E, Walleus H, Karlsson I, Eklund K, Forsman A, Nemeroff CB : "Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in neuropsychiatric disoerders" . Arch Gen Psychiatry . 43: 1148-1154 , 1986

88

Blum K, Noble E, Sheridan PJ, Montgomery A, Ritchie T,Jadadeeswaran P, Nogami H, Briggs AH, Cohn JB : "Allelic association of humane dopamine D2 receptor gene in alcoholism." JAMA. 263: 2055-2059 , 1990

Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D : "Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism" . JAMA. 263: 3156-3160 , 1990

Bondesson, U., Lindström, L.H .: "Determination of clozapine and its N-demethyliated metabolite in plasma by use of gas-chromatography-mass-spectometry with single ion detection" . Psychopharmacology . 95: 472-475 , 1988

Brown M, Fisher L, Spiess J, Rivier C, Rivier J, Vale W : "Corticoprotein-releasing factor: actions on the sympathetic nervous system and metabolism" . Endocrinology . 111: 928-931 , 1982

Buchsbaum MS, Haier RJ: "Psychopathology: biological approaches" . Ann Rev Psychol . 34: 310-430 , 1983

Caroll BJ : "Neuroendovrine function in mania" . In: Shopsin B (ed) Manic Illness. New York: Raven Press , 163-176 , 1979

Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, McJames N, Kronfol Z, Lohr N, Steiner M, deVigne JP, Young E : "A specific laboratory test for the diagnosis of melancholia." Arch Gen Psychiatry . 38: 15-22 , 1981

Chang KS, Trujillo JM, Pugh WC, Freireich EJ, Stass SA : "Developmental and differential regulation of human MPO gene in leukemic cells" . Leukemia . 4: 497-501 , 1990

Chang KS, Zhao S, Wang Y, Lu J, Trujillo JM, Stass SA, Freireich EJ : "Downregulation of myeloperoxidase gene associated with specific nuclease hypersensitive site during TPA-induced differentiation of HLA-60" . Leukemia. 5: 205-209 , 1991

Cholerton S, Daly A, Idle J: "The role of individual human cytochromes P450 in drug metabolism and clinical response." Trend Pharmacol Sci. 13: 434-439 , 1992

Ciraulo DA, Shader RI : "Fluoxetine drug-drug interactions. I. Antidepressants and antipsychotics."

89

Claas FHJ : "Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies" . Psychopharmacology (Berl). 99: S113-S117 , 1989

Claas, FHJ : "Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies" . Psychopharmacology . 99: S 113-117 , 1989

Clarke JB, Maggs JL, Kitteringham NR, Park BK: "Immunogenicity of amodiaquine in the rat" . Int Arch Allergy Appl Immunol . 91: 335-342 , 1990

Cloninger CR : "Neurogenetic adaptive mechanisms in alcoholism" . Science 236: 410-416 , 1987

Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Kane JM, Lieberman JA, Klein DN, MacMurray J, Tosk J, Sverd J, Gysin R, Flanagan S : "The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders" . JAMA . 266: 1793-1800 , 1991

Cook CCH, Brett P, Curtis D, Holmes D, Gurling MHD : "Linkage analysis confirms a genetic effect at the D2 dopamine receptor locus in heavy drinking and alcoholism" . Psychiatr Genet . 3: 130, 1993

Cookson JC, Silverstone T, Williams S, Besser GM : "Plasma cortisol levels in mania: Associated clinical ratings and changes during treatment with haloperidol" Br J Psychiatry . 146: 498-502 , 1985

Cornfield J: "A method of estimating comparative rates from clinical data: application to cancer of the lung, breast and cervix" . J Int Canc Inst . 11: 1269-1275 , 1951

Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA, Yunis EJ : "The major histocompatibility complex region marked by HSP 70-1 und HSP 70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups" . Blood . 86: 3835-3840 , 1995

Coutts RT : "Polymorphisms in the metabolism of drugs, including antidepressant drugs: Comments of phenotyping" . J Psychiatry Neurosci . 19: 30-44 , 1994

Cribb AE, Miller M, Tesoro A, Speilberg A : "Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs" . Mol Pharmacol . 38, 744-751 , 1990

90

Dewan MJ, Pandurangi AK, Boucher ML, Levy BF, Major LF : "Abnormal dexamethasone suppression test results in chronic schizophrenic patients" . Am J Psychiatry. 139: 1501-1503 , 1982

DiChiara G, Imperato A .: "Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats by ethanol" . Proc Natl Acad Sci USA . 85:970-977 , 1991

Eiermann B, Engel G, Johansson I, Zanger UM, Bertilsson L ": The involvement of CYP 1A2 and CYP 3A4 in the metabolism of clozapine" . Br J Clin Pharmacol . 44:439-446 , 1997

Engel JA, Enerback C, Fahlke C, Hulthe P, Hard E, Johannessen K, Svensson L, Söderpalm B : "Serotonergic and dopaminergic involvement in ethanol intake." In: Naranjo CA, Sellars EM: Novel Pharmacological Interventions for Alcoholism, Springer Inc., New York , pp 68-82, 1992

Feldmann S : "Neural pathways mediating adrenocortical responses" . Fed Proc . 44: 169-172 , 1985

Fischer V, Vogels V, Maurer G, Thynes RE : "The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6" . J Pharm Exp Ther . 260: 1355-1360 , 1992

Florio T, Ventra C, Postiglione A, Schettini G : "Age-related alterations of somatostatin gene expression in different rat brain areas" . Brain Res . 557: 64-68 , 1991

Furst, S.M., Uetrecht, J.P .: "Carbamazeine metabolism to a reactive intermediate by the myeloperoxidase system of activated neutrophils" . Biochemical Pharmacol , 45: 1267-1275 , 1993

Furutani Y, Morimoto Y, Shibahara S, Noda M, Takahashi H, Hiros T, Asai M, Inayama S, Hayashida H, Miyata T, Numa S : "Cloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor" . Nature . 301: 537-540 , 1983

Gatto GJ, Murphy JM, McBride WJ, Lumeng L, Li TK : "Intracranial self-administration of ethanol into the ventral tegmental area of alcohol-preferring rats" . Alcohol Clin Exp Res . 14: 291,

91

Gelernter J, O’Malley SO, Risch N, Kranzler HJ, Krystal J, Merikangas K, Kennedy JL, Kidd KK : "No association between an allele at the D2-dopamine receptor gene (DRD2) and alcoholism" . JAMA . 266: 1801-1807 , 1991

George DT, Lindquist T, Rawlings RR, Eckardt MJ, Moss H, Mathis C, Martin PR, Linnoila M: "Pharmacologic maintenance of abstinence in patients with alcoholism: no efficacy of 5-hydroxytryptophan or levodopa" . Clin Pharmacol Ther . 52: 553-560 , 1992

Gerner RH, Yamada T : "Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients" . Biol Psychiatry . 238: 298-302 , 1982

Gershon ES : "Genetic vulnerability in psychiatric epidemiology" . In Risk Factor Research in the Major Mental Disorders. Proceedings of a Conference, April 3-4, ADAMHA, Washington DC, 1980

Gerson STL, Meltzer H : "Mechanisms of clozapine-induced agranulocytosis" . Drug Safety . 7, Suppl. 1: 17-25 , 1992

Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G ": Low doses of ethanol activate dopaminergic neurons in the ventral tegmentum area" . Brain Res . 348: 201-203 , 1993

Gibbons JL : "Cortisol secretion in depressive illness" . Arch Gen Psychiatry . 10: 572-575 , 1964

Gold PW, Goodwin FK: Vasopressin in affective illness. Lancet 1233-1235 , 1978

Gold PW, Robertson GL, Ballenger GC : "Neurohypophyseal function in affective illness." Psychopharnacological Bull. 19: 426-431 , 1983

Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerios P, Schulte H, Oldfield E, Loriaux DL : "Psychiatric implications of basic and clinical studies with corticotropin-releasing factor." Am J Psychiatry . 141: 619-627 , 1984

Gold PW, Goodwin FK, Chrousos GP : "Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress (II)." N Engl J Med . 319: 413-420 , 1988

Goldman D, Dean M, Brown GL, Bolos AN, Tokola R, Virkunnen M, Linnoila M : "D2 dopamine receptor genotype and cerebral spinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States."

92

Goldstein AR, Patterson R : J. Allergy Clin. Immunol., 74: 643, 1984

Gonzalez FJ : "Human cytochromes P450: problems an prospects" . TIPS 13: 346-352 , 1995

Guillemin R, Rosenberg B: "Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures" . Endocrinology . 57: 599-607 , 1955

Häfner H, an der Heiden W: "Evaluation gemeindenaher Versorgung psychisch Kranker. Ergebnisse von 4 Jahren wissenschaftlicher Begleitung der Aufbauphase des Mannheimer Modells" . Arch Psychiatr Nervenkr 232: 71-95 , 1982

Hamilton M : "A rating scale for depression" . J Neurol Neurosurg Psychiatry . 23: 56-62 , 1960

Harris GW : "Neural control of the pituitary gland" . Physiol Rev . 28: 139-179 , 1948

Harrison J, Araiso T, Palcic M, Dunford H: "Compound I of myeloperoxidase" . Biochem Biophys Res Commun . 94: 34-40 , 1980

Hashinaka K, Nishio C, Hur SJ, Sakiyama F, Tsunasawa S, Yamada M: "Multiple species of myeloperoxidase mRNAs produced by alternative splicing and differential polyadenylation" . Biochemistry . 27: 5906-5914 , 1988

Hashinaka K, Yamda M : "Undermethylation and Dnase 1 hypersensitivity of myeloperoxidase gene in HL-60 cells before and after differentiation" . Arch Biochem Biophys. 293: 40-45 , 1992

Helmchen H : "Clinical experience with clozapine in Germany." Psychopharmacology . 99: S 80-83 , 1989

Holsboer F, Mueller OA, Doerr HG, Sippell WG, Stalla GK, Gerken A, Steiger A, Boll E, Benkert O : "ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: relationship to multisteroid responses after ACTH-stimulation and dexamethasone suppression" . Psychoneuroendocrinology . 9: 147-160 , 1984

Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Müller OA : "Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor (h-CRF) in depression." N Engl J Med. 311: 1127, 1984

Holsboer F, von Bardeleben U, Buller R, Heuser I, Steiger A : "Stimulation response to "

93

Holsboer F, Spengler D, Heuser I : "The role of corticotropin-releasing hormone in the pathogenesis of Cushing’s disease, anorexia nervosa, alcoholism, affective disorders and dementia" . Prog Brain Res . 93: 385-417 , 1992

Holsboer F : "The rationale for corticotropin-releasing-hormone receptor (CRH-R) antagonists to treat depression and anxiety" . J Psychiatric Res . 33: 181-214 , 1999

Holsboer-Trachsler E, Stohler R, Hatzinger M : "Repeated administration of the combined dexamethasone/hCRH stimulation test during treatment of depression" . Psychiatry Res . 38: 32-38 , 1991

Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker W ".: Clozapine induced transient white blood count disorders" . J Clin Psychiatry . 55:10, 1994

Hummer M, Sperner-Unterweger B, Kemmler G, Falk M, Kurz M, Oberbauer H, Fleischhacker WW : "Does eosinophilia predict clozapine induced neutropenia?" Psychopharmacology . 124: 201-204 , 1996

Ichihara S, Tomisawa H, Fukazawa H, Tateishi M, Joly R, Heintz R : "Involvement of leukocyte peroxidases in the metabolism of tenoxicam" . Biochem Pharmacol . 34: 1337-1338 , 1985

Ichikawa J : "Clinical observations of the effect of antipsychotic drugs" . Second Leponex Scientific Update Meeting . Florence, 1991

Inman WH : "Blood disorders and suicide in patients taking mianserin or amitriptyline." Lancet . 2: 90-92 , 1988

Iwahashi K : "CYP 2D6 genotype and possible susceptibility to the neuroleptic malignant syndrome" . Biol Psychiatry . 36: 780-782 , 1994

Janowski DS, El-Yousef MK, Davis JM, Sekerke HJ : "A cholinergic-adrenergic hypothesis of mania and depression" . Lancet . 632-635 , 1972

Janssen PAJ : "Vergleichende pharmakologische Daten über sechs neue basische 4`-Fluorobutyrophen-Derivate. Haloperidol, Haloanison, Triperidol, Methylperidid, Haloperidid und Dipiperon. 1. Und 2. Mitteilung." Arzneimittelforschung . 11: 819-824, 932-938 , 1961

94

Kalin NH, Shelton SE, Barksdale CM: "Behavioural and physiological effects of CRH administered to infant primates undergoing maternal separation." Neuropsychopharmacology . 2: 97-104 , 1989

Kaplow LS : "The relationship of myeloperoxidase activity to neutrophil maturity and other hematologic indicators of infection" . Blood Cells Mol Dis . 12: 153-156, 1986

Keller SE, Weiss JM, Schleifer SJ, Miller NE, Stein M : "Suppression of immunity by stress: effect of a grated series of stressors on lymphocyte stimulation in the rat" . Science . 213: 1397-1400 , 1981

Keller-Wood ME, Dallmann MF : "Corticosteroid inhibition of ACTH secretion" . Endocr Rev. 5: 1-24 , 1984

Kennedy SH, Tighe S, Mc Vey G, Crown GM : "Melatonin and cortisol switches during mania, depression, and euthymia in drug-free bipolar patient." J Nerv Ment Dis . 177: 300-303 , 1989

Kettle AJ, Winterbourn CC : "Mechanisms of inhibition of myeloperoxidase by anti-inflammatory drugs" . Biochem Pharmacol . 41: 1485-1492 , 1991

Klebanoff SJ, Clark RA : "The Neutrophil: Function and Clinical Disorders" , Elsevier/North-Holland, Amsterdam , 1978

Kline NS: "Use of rauwolfia serpentina benth in neuropsychiatric conditions" . Ann NY Acad Sci . 59:107, 1954

Kono Y, Yoneda H, Sakai T, Nonomura Y, Inayama Y, Koh J, Sakai J, Inada Y, Imamichi H, Asaba H : "Association between early onset alcoholism and the dopamine D2 receptor gene" . Am J Med Genet . 74: 179-182 , 1997

Koob GF, Bloom FE : "Corticotropin-releasing factor and behaviour" . Fed Proc 44: 259-263 , 1985

Koob GF and Bloom FE : "Cellular and molecular mechanisms of drug dependence" . Science . 242: 715-723 , 1988

Koob GF : "Drugs of abuse: Anatomy, pharmacology, and function of of reward pathways" . Trends

95

Kuhn R : "Über die Behandlung depressiver Zustände mit einem Iminibenzyl-Derivat (G 22355)" Schweiz Med Wochenschr . 87: 1135-1140 , 1957

Kupfermann I : "Hypothalamus and limbic system: peptidergic neurons, homeostasis, and emotional behaviour." In: Kandel ER, Schartz JH, Jessel TM (eds) Principles of neuroscience, 3. Auflage Elsevier , New York, Amsterdam, London, Tokyo 735-749 , 1991

Laborit H, Huguenard P : "L’hibernation artificielle par moyens pharmacodynamiques et physiques." Presse Med . 59: 1329, 1951

Laignel-Lavastine M : "The Internal Secretion and the Nervous System." Nerval and mental Publishing Co, New York , 1919

Lanza F, Fietta A, Spisani S, Castoldi GL, Traniello S : "Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms" ? J Clin Lab Immun . 22: 175-180 , 1987

Lawford Br, Young RM, Rowell JA, Gibson JN, Feeney GFX, Ritchie TL, Syndulko K, Noble EP: "Association of the D2 dopamine receptor A1 allele with alcoholism: Medical severity of alcoholism and type of controls" . Biol Psychiatry . 41:386-393 , 1991

Levin ML : "The occurrence of lung cancer in man" . Acta Un Int.Cancr . 19: 531-541 , 1953

Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis E .: "HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in jewish patients with schizophrenia" . Arch Gen Psychiatry. 47:945-948 , 1990

Lieberman J, Yunis J, Egea E, Canoso RT, Kane JM, Yunis E : "HLA-B38, DR 4, DQw3 and clozapine-induced agranulocytosis in jewish patients with schizophrenia" . Arch Gen Psych . 47: 945-948 , 1990

Linkowski P, Mendlewicz J, Leclerq R, Brasseur M, Hubain P, Goldstein J, Copinschi G, vanCauter E : "The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness" . J Clin Endocrinol Metab . 61: 429-438 , 1985

Llerena A, Herraiz AG, Cobaleda J, Johansson I, Dahl ML : "Debrisoquin and mephenytoin hydroxylation phenotypes and CYP 2D6 genotype in patients treated with neuroleptic and antidepressant agents" . Clin Pharmacol Ther . 54: 606-611 , 1993

96

Loomer HP, Saunders IC, Kline NS : "A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer" . Psychiatr Res Publ Am Psychiatr Assoc . 8: 129, 1957

Love BB, Biller J, Gent M: " Adverse haematological effects of ticlopidine. Prevention, recognition, and management" . Drug Safety . 19: 89-98 , 1998

Lübbert M, Miller CW, Koeffler HP : "Changes of DNA methylation and chromatin structure in the human myeloperoxidase gene during myeloid differentiation" . Blood . 78: 345-356 , 1991

Mandl DL, Garrison MW, Palpant SD: "Agranulocytosis induced by vancomycin or ticarcillin/clavulanate" . Ann Pharmacother. 31: 1321-1324 , 1997

Matussek N, Ackenheil M, Hippius H, Muller F, Schroder HAT, Schultes H, Wasilewski B: " Effect of clonidine on growth hormone release in psychiatric patients and controls" . Psychiatry Res. 2: 25-36 , 1980

Meltzer HY, Goode DJ, Fang VS : "The effect of psychotropic drugs on endocrine function. I. Neuroleptics, precusors and agonists." In Psychopharmacology: A Generation of Progress (eds: Lipton MA, Di Mascio A and Killam KF) New York, Raven Press. 1978

Meltzer HY, Busch D, Fang VS : "Hormones, dopamine receptors and schizophrenia" . Psychoneuroendocrinol . 4: 17-36 , 1981

Meltzer HY, Lowy MT: "The serotonin hypothesis of depression" . In Meltzer HY (ed.) Psychopharmacology: The third generation of progress. Raven Press, New York, 1987

Meltzer HY, Cola BA, Lynne Way L, Thompson PA, Bastani B, Davies MA, Snitz B : "Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia." Am J Psychiatry. 150: 1630-1638 , 1993

Morishita K, Tsuchiya M, Asano S, Kagiro Y, Nagata S : "Chromosomal gene structure of human myeloperoxidase and regulation of its expression by granulocyte colony-stimulationg factor" . J Biol Chem . 262: 15208-15213 , 1986

Mortimer O, Persson K, Ladona MG, Spalding D, Zanger UM, Meyer UA, Rane A: "Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextrometorphan: Relationship to the presence of immunoidentified cytochrome P 450 "

97

Muller P, Britton RS, Seeman P : "The effects of long term ethanol on brain receptors for dopamine, acetylcholine, serotonin and noradrenaline" . Eur J Pharmacol . 65:31-37 , 1980

Murphy BEP, Conneely OM : "Neuroendocrine regulation of the hypothalamic-pituitary-adrenal axis by the nur 1 77 subfamily of nuclear receptors" . Mol Endocrinol . 11: 39-47 , 1997

Neiswanger K, Hill SY, Kaplan BB : "Association and lonkage studies of the Taq 1 A allele of the dopamine D2 receptor gene in samples of female and male alcoholics" . Am J Med Genet . 60: 267-271 , 1995

Nemeroff CB, Widerlöv E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CS, Loosen PT, Vale W : "Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients" . Science . 226: 1342-1344 , 1984

Nemeroff CB, Bissette G; Akil H, Fink M : "Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with ECT" . Br J Psychiatry 158: 59-63 , 1992

Nemeroff CB .:" Dosing the antipsychotic olanzapine" . J Clin Psychiatry. 10:45-9 , 1997

Overall JE, Gorham DR : "The Brief Psychiatry Rating Scale" . Psychol Rep . 10: 799-812 , 1962

Park BK, Coleman JW : "The immunologic basis of adverse drug reactions" . A report on a symposium held in Liverpool on 6th April 1988. Br J Clin Pharmacol . 26: 491, 1988

Pato CN, Macciardl F, Pato MT, Verga M, Kennedy JL : "Review of theputative association of D2 receptot and alcoholism: A meta-analysis. " Am J Med Genet. 48: 78-82 , 1994

Plotsky PM, Otto S, Sutton S : "Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation" . Life Sci. 41: 91-115, 1987

Pohl LR, Satoh H, Christ DD, Kenna JG : "The immunologic and metabolic basis of drug hypersensitivities" . Ann Rev Pharmacol Toxicol . 28: 367-387, 1988

Polednak A : "Racial and ethnic differences in disease" : New York: Oxford University Press , 1992

98

Reichlin S : "Somatostatin in the nervous system" . In Schmitt F.O.; Bird, S.J.; Bloom, F.E.: Molecular Genetic Neuroscience . New York: Raven Press, pp 359-372, 1982

Reichlin S : "Somatostatin." N. Engl J Med . 309: 1495-1501, 1983

Renwick JH : "Elucidation of gene order" . In Recent Advances in Human Genetics (Edited by Penrose LS ) Little&Brown, Boston, 1961

Rezek M, Havlicek V, Hughes KR, Friesen H : "Behavioral and motor excitation and inhibition induced by the administration of small and large doses of somatostatin into the amygdala" . Neuropharmacology . 16: 157-162, 1977

Roberts DCS, Bloom FE : "Adrenal steroid-induced changes in beta-adrenergic receptor binding in rat hippocampus" . Eur J Pharmacol . 74: 37-41, 1981

Rolandi E, Barreca T : "Neuropharmacological influences on hypothalamic-pituitary secretion" . In: Shah NS, Donald AG (eds): Psychoneuroendocrine dysfunction . Plenum Press, New York 41-71, 1984

Rommelspacher H, Raeder C, Kaulen P, Brüning G : "Adaptive changes of Dopamine-D2-receptors in rat brain following ethanol withdrawal: a quantitative autoradiographic investigation" . Alcohol. 9:355-362, 1992

Rothpearl AB, Mohs RC, Davis KL : "Statistical power in biological psychiatry" . Psychiat Res . 5: 257-266, 1981

Rotrosen J, Angrist B, Gershon S, Paquin J, Branchey L, Oleshansky M, Halpern F, Sachar EJ: "Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research" . Brit J Psychiat . 135: 444-456, 1978

Roy MB, Pickar D, Doran A, Wolkowitz O, Gallucci W, Chrousos G, Gold P : "The corticotropin-releasing hormone stimulation test in chronic schizophrenia" . Am J Psychiatry . 143: 1393-1397, 1986

Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW : CSF "Corticotropin-releasing hormone in depressed patients and normal control subjects" . Am J Psychiatry. 144: 641-645, 1987

99

Sachse C, Brockmöller J, Bauer S, Roots I.: " Functional significance of a C/A polymorphism in intron 1 of the cytochrome P450 1A2 (CYP1A2) gene tested with caffeine" . Br J Clin Pharmacol . 47:445-449, 1999

Saffran M, Schally AV, Benfey BG : "Stimulation of the release of corticotropin from the adenohypophysis by a neurohypophysial factor" . Endocrinology . 57: 439-444, 1955

Salize HJ, Rössler W ": Steigen die Versorgungskosten von Patienten mit Schizophrenie überproportional?" Nervenarzt 70: 817-822, 1999

Samson HH, Tolliver GA, Haraguchi M, Kalivas PW : "Effects of d-amphetamine injected into the nucleus accumbens on ethanl reinforced behavior" . Brain Res Bull . 27: 267-271, 1991

Sandborg RR, Smolen JE ": Early biochemical events in leukocyte activation" . Lab Invest. 59: 300-320, 1988

Sass H, Soyka M, Mann K, Zieglgänsberger W : "Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence" . Arch Gen Psychiatry . 53: 673-80, 1996

Scharrer E, Scharrer B : "Hormones produced by neurosecretory cells" . Recent Prog Horm Res. 10:183-232, 1954

Scharrer E, Scharrer B : "Secretory cells within the hypothalamus" . In: The Hypothalamus , Fulton JF (Ed)Vol. 20, 170-194, 1939

Schettini G, Florio T, Magri G, Grimaldi M, Meucci O, Landolfi E, Marino A : "Somatostatin and SMS 201-995 reverse the impairment of cognitive functions induced by cysteamine depletion of brain somatostatin" . Eur J Pharmacol . 35: 355-357, 1988

Schildkraut JJ: "The catecholamine hypothesis of affective disorders: a review of supporting evidence" . Am J Psychiatry . 122: 509-522, 1965

Schmidt LG, Dufeu P, Kuhn S, Rommelspacher H : "Relapse prevention in alcoholics with an anticraving drug treatment: first results of the Berlin Study" . Pharmacopsychiatry . 1: 21-3, 1994

100

Schukitt MA : "Advances in understanding the vulnerability to alcoholism" . In: O'Brien CP and Jaffe JH (eds): Addictive States, Raven Press , Ltd. New York, pp 93-108, 1992

Seligman MEP, Maier SF: "Failure to escape traumatic shock" . J Exp Psychol 74: 1-9, 1976

Sellers EM, Otton SV, Tyndale RF : "Pharmacogenetics of CYP 2D6: Implications for substance abuse and other disorders" . Abstracts of Panels and Posters p69. Presented at the 33 rd Annual meeting of the American College of Neuropharmacology , December, 1995

Shackelford DA, Kaufman JF, Korman AJ, Strominger JL ".: HLA-antigens: structure, separation of subpopulations, gene cloning and function" . Immunol Rev . 66:133-87, 1982

Shibahara S, Morimoto Y, Furutani Y, Notahe M, Takahashi H, Shimizu S, Horikawa S, Numa S : "Isolation and sequence analysis of the human corticotropin releasing factor precursor gene." EMBO J. 2: 775-759, 1983

Sirinathsinghij DJS, Nikolarakis KE, Herz A : "Corticotropin-releasing factor stimulates the release of methionine-enkephalin and dynorphin from the neostriatum and globus pallidus of the rat: in vitro and in vivo studies" . Brain Res . 490: 267-291, 1989

Sörensen KV, Christensen SE, Dupont E, Hansen, AP, Pedersen E, Orskov H : "Low somatostatin content in cerebrospinal fluid in multiple sclerosis" . Acta Neurol Scand . 61: 186-191, 1980

Spanagel R, Zieglgänsberger W : "Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes" . Trends Pharmacol Sci. 18:54-9, 1997

Spina E, Avenoso A, Facciola G, Fabrazzo M, Monteleone P, Maj M, Perucca E, Caputi AP : "Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites with schizophrenia" . Int Clin Psychopharmacol. 13:141-145, 1998

Stalla GK, Hartwimmer J, von Werder K, Müller OA: "Ovine(o) and human(h) corticotropin-releasing factor (CRF) in man: CRF-stimulation and CRF-immunoreactivity" . Acta Endocrinol. (KBH) 106: 289-297, 1984

Strausbaugh H, Irwin M : "Central corticotropin-releasing hormone reduces cellular immunity." Brain Behav Immun 6: 11-17, 1992

101

Sylvälathi EKG, Hietala J, Räyttä M, Gränroos J.: "Decrease in the number of rat brain dopamine and muscarine receptors after chronic ethanol intake" . Pharmacol Toxicol . 62: 210-212, 1988

Synder SH : "Catecholamines in the brain as mediators of amphetamine psychosis" . Arch Gen Psychiatry . 27: 169-178, 1972

Tabakoff B, Hoffmann PL, Ritzmann RF ": Dopamine receptor function after chronic ingestion of alcohol" . Life Sci . 23:643-648, 1978

Timpl P, Spanagel R, Sillaber I, Krese A, Reul JMHM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W ": Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1" . Nature Genet. 19: 162-166, 1998

Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV : "Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: Evidence for synergy between vasopressin and corticotropin-releasing hormone in humans" . J Clin Endocrinol Metab . 79: 140-144, 1994

Tucker GT, Lennard MS, Ellis SW, Woods HF, Cho AK, Lin LY, Hiratsuka A, Schmitz DA, Chu TY : "The demethylenation of methylenedioxymethamphetamine (“ecstasy“) by debrisoquine hydroxylase (CYP2D6)" Biochem Pharmacol 47: 1151-1156, 1995

Uetrecht JP, Zahid N, Shaer NH, Biggar WD : "Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells" . J Pharmacol Exp Ther. 245: 274-279, 1988

Uetrecht JP, Zahid N : "N-chlorination of phenytoin by myeloperoxidase to a reactive metabolite" . Chem Res Toxicol. 1: 148-151, 1988

Uetrecht JP : "Idiosyncratic drug reactions: possible role of reactive metabolites ge-nerated by leukocytes." Pharm Res . 6: 265-273, 1989

Uetrecht JP, Zahid N : "N-Chlorination and oxidation of procainamide by myeloperoxidase: Toxicological implications" . Chem Res Toxicol . 4: 218-222, 1991

Uetrecht JP : "Myeloperoxidase as a generator of drug free radicals" . Biochem Soc Symp . 61: 163-170, 1995

102

Vale W , Spiess J, Rivier C, Rivier J : "Characterization of a 41-residue hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin" . Science . 213: 1394-1397, 1981

Vale W, Vaughan J, Yamamoto G, Bruhn T, Douglas C, Dalton D, Rivier C, Rivier J : "Assay of corticotropin releasing factor." Methods Enzymol . 103: 565-577, 1983

Vecsei L, Schwarzberg H, Telegdy G : "The effect of somatostatin on the self-stimulation of rats." Neuroendocrinology Lett . 4: 37-40, 1983

Vecsei L, Kiraly CS, Bollok I, Nagy A, Varga J, Penke B, Telegdy G : "Comparative studies with somatostatin and cysteamine in different behavioral tests on rats" . Pharmacol Biochem Behav. 21: 833-837, 1984

Vescovi PP, Volpi R, Coiro V : "Alcoholism abolishes the gamma-aminobutyric acid (GABA)ergic control of GH secretion in humans" . Alcohol . 16: 325-328, 1998

Vlahov V, Bacracheva N, Tontcheya D, Naumova E, Mavrzdieva M, Illieva P, Michailova A: "Genetic factors and risk of agranulocytosis from metamizol" . Pharmacogenetics . 6: 67-72, 1996

Von Bardeleben U, Stalla GK, Müller OA, Holsboer F : "Blunting of ACTH-Response to h-CRH in depressed patients is avoided by metapyrone treatment" . Biol Psychiatry . 24: 782-786, 1988

Von Bardeleben U, Heuser I, Holsboer F : "Dose-dependant suppression of CRH releasable ACTH by dexamethasone in normal controls" . Eur Arch Psychiatry Clin Neurosci . 1992

Waldhauser L, Uetrecht JP : "Oxidation of propylthiouracil to reactive metabolites by activated neutrophils: Implications for agranulocytosis" . Drug Metab Dispos . 19: 354-359, 1991

Weil SC, Rosner GL, Reid MS, Chisholm RL, Lemons RS, Swanson MS, Carrino JJ, Diaz MO, LeBeau MM : "Translocation and rearrangement of myeloperoxidase gene in acute promyelocytic leukemia" . Science . 240: 790-792, 1988

Weiss SJ : "Tissue destruction by neutrophils" . N Engl J Med . 320: 365-376, 1989

Weiss F, Mitchiner M, Bloom FE, Koob GF : "Free-choice responding for ethanol versus water in "

103

Weiss F, Lorang MT, Bloom FE, Koob GF : "Ethanol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants" . J Pharmacol Exp Ther. 1993

Wiesbeck GA, Mueller T, Wodarz N, Davids E, Kraus T, Thome J, Weijers HG, Boening J: "Growth hormone response to placebo, apomorphine and growth hormone releasing hormone in abstinent alcoholics and control subjects" . Drug Alcohol Depend . 52: 53-56, 1998

Wiesbeck GA, Weijers HG, Chick J, Naranjo CA, Boening J : "Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial" . Alcohol Clin Exp Res . 23: 230-235,1999

Whalley LJ, Christie JE; Blackwood DHR, Bennie J, Dick H, Blackburn IM, Fink G : "Disturbed endocrine function in the psychoses I: Disordered homeostasis or disease process" ? Br J Psychiatry . 155: 455-461, 1989

Whybrow TC, Horwitz T : "Psychologica disturbances associated with endocrine disease and hormone therapy." In: Sachar EJ(ed.) Hormones, behaviour and psychpathology . Raven Press, New York 15-44, 1976

Wittchen HU, Zaudig M, Schramm E, Spengler P, Mombour W, Klug J, Horn R : SKID, "Strukturiertes Klinisches Interview für DSM-III-R" . Beltz Test, Weinheim 1990

Wolley PH, Griffin J, Panayi GS, Batchelor JR .: "HLA-DR antigens and toxic reaction to sodium aurothiomalite and D-penicillinamine in patients with rheumatoid arthritis" . N Engl J Med. 303:300-302, 1980

Ysewin-van Brussel KARN, de Leenheer AP : "Development and evaluation of a radioimmunosassay for arg8 vasopressin, after extraction with sep-pak C18." Clin Chem . 31: 861-863, 1985

Yunis JJ, Lieberman JA, Yunis EJ .: "Major histocompatibility complex associations with clozapine-induced agranulocytosis." Drug Safety . 1:7-9, 1992

Yunis JJ, Corzo D, Salazar M, Lieberman JA, Howard A, Yunis EJ ".: HLA associations in "

104

3

Dettling M: "Neuropeptidhormon-Konzentrationen von Corticotropin-Releasing-Hormon, Vasopressin und Somatostatin im spinalen Liquor von depressiven Patienten und Probanden vor und nach Behandlung mit Antidepressiva" . Dissertation zum Erwerb des Doktorgrades der Medizin an der Medizinischen Fakultät der Ludwig-Maximilians-Universität zu München , München, 1994

Heuser IJE, Gotthard U, Schweiger U, Schmider J, Lammers C.-H, Dettling M, Holsboer F : "Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender" . Neurobiol Aging. 15: 227-231, 1994

Dettling M, Heinz A, Dufeu P, Rommelspacher H, Gräf KJ, Schmidt LG : "Dopaminergic responsivity in alcoholism: trait, state, or residual marker?" Am J Psychiatry . 152: 1317-1321, 1995

Schmider J, Lammers CH, Gotthard U, Dettling M, Holsboer F, Heuser IJE : "Combined dexamethasone/corticotropin-releasing-hormone test in acute and remitted manic patients, in acute depression and in normal controls" . Biol Psychiatry . 38: 797-802, 1995

Lammers CH, Garcia-Borreguerro D, Schmider J, Gotthard U, Dettling M, Holsboer F, Heuser IJE : "Combined dexamethasone/corticotropin-releasing-hormone test in patients with schizophrenia and in normal controls" . Biol Psychiatry . 38: 803-807, 1995

Heinz A, Dettling M, Kuhn S, Dufeu P, Gräf KJ, Kürten I, Rommelspacher H, Schmidt LG: "Blunted growth hormone response is associated with early relapse in alcohol-dependent patients" . Alcohol Clin Exp Res . 19: 62-65, 1995

Heinz A, Lichtenberg-Kraag B, Sallström-Baum S, Gräf KJ, Krüger F, Dettling M, Rommelspacher H : "Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome" . J Neural Transm Gen 102:149-157, 1995

Dettling M, Tretter, F : "Der "Opiatentzug in Narkose" bei Opiatabhängigkeit: Entzugs-behandlungen im Wandel der Zeit-Wunsch und Wirklichkeit" . Nervenarzt . 67: 805-810, 1996

Heuser IJE, Gotthard U, Schmider J, Lammers CH, Schweiger U, Dettling M, Grasser A, Holsboer F : "Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects" . Am J

4

Heinz A, Dufeu P, Kuhn S, Dettling M, Gräf KJ, Kürten I, Rommelspacher H, Schmidt LG: "Psychopathological and behavioral correlates of reduced dopaminergic sensitivity in alcoholism" . Arch Gen Psychiatry . 53: 1123-1128, 1996

Schmidt LG, Dettling M, Gräf KJ, Heinz A, Kuhn S, Podschus J, Rommelspacher H : "Reduced dopaminergic function is related to severe dependence" . Biol Psychiatry. 39: 193-198, 1996

Heinz A, Sander T, Harms H, Finckh U, Kuhn S, Dufeu P, Dettling M, Gräf KJ, Rolfs A, Rommelspacher H, Schmidt LG ": Lack of allelic association of dopamine D1 and D2 (Taq IA) receptor gene polymorphisms with reduced dopaminergic sensitivity in alcoholism" . Alcohol Clin Exp Res . 20: 1109-1113, 1996

Heinz A, Dufeu P, Kuhn S, Dettling, M., Podschus J, Gräf K, Rommelspacher H, Schmidt LG: "Reduced dopaminergic sensitivity is associated with low levels of depression, but not craving, in alcohol-dependent patients with poor treatment outcome" . Alcoholism . 32: 19-27, 1996

Dettling M, Müller-Oerlinghausen B, Rolfs A: "Pathomechanisms of clozapine-induced agranulocytosis-impact of genetic determinants" . Naunyn-Schmiedeberg’s Archives of Pharmacology. 355: 4, suppl., 1997

Finckh U, Rommelspacher H, Kuhn S, Dufeu P, Otto G, Heinz A, Dettling M, Giraldo-Velasquez M, Pelz J, Gräf KJ, Harms H, Sander T, Schmidt LG, Rolfs A ": Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism" . Pharmacogenetics. 7 (4): 271-281, 1997

Dettling M, Müller-Oerlinghausen B, Britsch P : "Clozapine treatment of HIV-associated psycho-sis: Too much bone marrow toxicity?" Pharmacopsychiatry . 31: 156-157, 1998

Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F : "Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment" . Depression and Anxiety . 8: 71-79, 1998

Dettling M, Cascorbi I, Hellweg R, Deicke U, Weise L, Müller-Oerlinghausen B: "Genetic determinants of drug-induced agranulocytosis-potential risk of olanzapine?" Pharmacopsychiatry . 32: 110-112,1999

Sachse C, Ruschen S, Dettling M, Schley J, Bauer S, Müller-Oerlinghausen B, Roots I, Brockmöller J : "Flavin monooxygenase (FMO3) polymorphism in a caucasian population: allele frequencies, mutation linkage and functional effects on clozapine and caffeine metabolism" . Clinical Pharmacology and Therapeutics. 66: 431-438. 1999

Dettling M, Cascorbi I ,Roots I, Müller-Oerlinghausen B: "Genetic determinants of clozapine-induced agranulocytosis-recent results of HLA-subtyping in a non-Jewish caucasian sample" . Arch Gen Psychiatry . In press, 2000

Dettling M, Sachse C, Müller-Oerlinghausen B, Roots I, Brockmöller J, Rolfs A, Cascorbi I : "Lack of association between clozapine-induced agranulocytosis and hereditary polymorphisms of drug metabolizing enzymes myeloperoxidase and cytochrome P450 2D6" . Pharmacopsychiatry . In press, 2000

5

Dettling M, Schaub RT, Müller-Oerlinghausen B, Roots I, Cascorbi I: "Further evidence of human-leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry" . Submitted, 2000

Kaiser R, Könneker M, Henneken M, Dettling M, Müller-Oerlinghausen B, Roots I, Brockmöller J : "Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia" . Molecular Psychiatry . In press, 2000

Kaiser R, Brockmöller J, Henneken M, Tremblay PB, Schmider J, Dettling M, Müller-Oerlinghausen B, Roots I : "Serotonin transporter polymorphisms: no associations with response to antipsychotic treatment, but association of the 17 bp VNTR with schizophrenia" . Submitted, 2000

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.